Analysis Of Eribulin Mesylate Dosing Modifications Impact On Administration Persistence In Patients With Metastatic Breast Cancer (Mbc)
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1043
https://www.valueinhealthjournal.com/article/S1098-3015(15)03119-8/fulltext
Title :
Analysis Of Eribulin Mesylate Dosing Modifications Impact On Administration Persistence In Patients With Metastatic Breast Cancer (Mbc)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03119-8&doi=10.1016/j.jval.2015.09.1043
First page :
A434
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
543